Healthcare Research Development from 2010 to 2024

603313 Stock   7.53  0.14  1.89%   
Healthcare's Research Development is increasing over the years with slightly volatile fluctuation. Research Development is expected to dwindle to about 78.7 M. From 2010 to 2024 Healthcare Research Development quarterly data regression line had arithmetic mean of  68,723,234 and r-squared of  0.79. View All Fundamentals
 
Research Development  
First Reported
2019-03-31
Previous Quarter
33 M
Current Value
41.2 M
Quarterly Volatility
6.4 M
 
Covid
Check Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 224.7 M, Selling General Administrative of 1.5 B or Total Revenue of 8.4 B, as well as many indicators such as . Healthcare financial statements analysis is a perfect complement when working with Healthcare Valuation or Volatility modules.
  
This module can also supplement various Healthcare Technical models . Check out the analysis of Healthcare Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Healthcare Stock

Healthcare financial ratios help investors to determine whether Healthcare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthcare with respect to the benefits of owning Healthcare security.